Suppr超能文献

非人灵长类动物中的黄热病:从“同一个健康”视角出发的兽医指南

Yellow Fever in Non-Human Primates: A Veterinary Guide from a One Health Perspective.

作者信息

Nederlof Remco A, Virgilio Tommaso, Stemkens Hendrickus J J, da Silva Luiz C C Pereira, Montagna Daniela R, Abdussamad Abdussamad M, Chipangura John, Bakker Jaco

机构信息

Independent Researcher, 2861 XZ Bergambacht, The Netherlands.

Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.

出版信息

Vet Sci. 2025 Apr 6;12(4):339. doi: 10.3390/vetsci12040339.

Abstract

Yellow fever (YF) causes severe morbidity and mortality in Africa and South America. It is an arthropod-borne viral disease endemic to tropical regions of Africa and South America. Yellow fever virus (YFV) is transmitted by mosquitoes and frequently affects both non-human primates (NHPs) and humans. Neotropical primates (NTPs) are generally more severely afflicted by YFV than African primates. Asian primates appear not to be susceptible to this disease. Susceptibility varies among NTP species: asymptomatic infections are described in some NTP species, whereas severe epizootic mortality events are described in others. The genus (howler monkeys) is considered to be the most susceptible among the NTPs. Epizootic events resulting in the death of thousands of NTPs have been recorded in recent history. As a result, YFV poses a threat to the survival of some NTP species. In most cases, NTPs are found dead without showing prior clinical signs. In cases where clinical signs are observed, they are mostly non-specific. Due to their high susceptibility, epizootic events in NTPs are used as epidemiological predictors for human YF outbreaks. YFV infection may be diagnosed by means of virus isolation, reverse transcription polymerase chain reaction, serology, histopathology, or immunohistochemistry. Animals that survive the disease develop neutralizing antibodies to YFV. Currently, no specific treatment is available. Sustained YF control strategies must rely on surveillance and accurate diagnostics to allow for early detection of outbreaks and rapid implementation of control measures. Prophylaxis should be based on a One Health perspective that recognizes the intricate interplay between human health, primate health, and the environment. Vaccines for YF are available, with the human 17DD vaccine effectively preventing disease in primates. However, mitigation strategies continue to rely more and more on vector control, preferably using eco-friendly methods. Climate change and human activities, and their impact on local ecology, are assumed to increase the risk of YF transmission in the next decades.

摘要

黄热病(YF)在非洲和南美洲会导致严重的发病和死亡。它是一种节肢动物传播的病毒性疾病,在非洲和南美洲的热带地区流行。黄热病毒(YFV)通过蚊子传播,经常影响非人类灵长类动物(NHPs)和人类。新热带灵长类动物(NTPs)通常比非洲灵长类动物更容易受到YFV的严重影响。亚洲灵长类动物似乎对这种疾病不敏感。NTP物种之间的易感性各不相同:一些NTP物种描述为无症状感染,而其他物种则描述为严重的动物流行病死亡事件。蛛猴属在NTPs中被认为是最易感的。近年来记录了导致数千只NTP死亡的动物流行病事件。因此,YFV对一些NTP物种的生存构成威胁。在大多数情况下,NTPs被发现死亡时没有表现出先前的临床症状。在观察到临床症状的情况下,它们大多是非特异性的。由于它们的高易感性,NTPs中的动物流行病事件被用作人类黄热病爆发的流行病学预测指标。YFV感染可以通过病毒分离、逆转录聚合酶链反应、血清学、组织病理学或免疫组织化学进行诊断。从疾病中存活下来的动物会产生针对YFV的中和抗体。目前,没有特效治疗方法。持续的黄热病控制策略必须依靠监测和准确的诊断,以便早期发现疫情并迅速实施控制措施。预防应基于“同一健康”的观点,该观点认识到人类健康、灵长类动物健康和环境之间的复杂相互作用。有黄热病疫苗,人类17DD疫苗可有效预防灵长类动物发病。然而,缓解策略越来越依赖病媒控制,最好使用环保方法。气候变化和人类活动及其对当地生态的影响,被认为会在未来几十年增加黄热病传播的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/12031500/efba73f5a69c/vetsci-12-00339-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验